Australis Scientific raises $9.3 million for smart patch that replaces adult diapers

▤ Summary

Australis Scientific has raised $9.3 million from Rohto Pharmaceutical to accelerate development of its Confidanz smart patch. The wearable targets overactive bladder by delivering tibial nerve stimulation near the ankle and offers a less invasive alternative to surgery, medication, or clinical procedures. The company is already running its first-in-human trial in Australia and plans to use the results for regulatory filings in Australia, the US, and Japan. The investment also supports expansion into Japan and China, where Rohto’s distribution channels and digital therapeutics focus could speed commercialization.

$ Funding

▦ Linked Companies